rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Jeremy Yarwood

Chief Scientific Officer

Company insider

Files Form 4 as: Chief Scientific Officer, Neogen.

In numbers

Trades disclosed
3
Buys
0
Sells
1
Bought
$0
Sold
$115K
Companies
1
Companies where not an officer
0
First trade
3 Nov 2026
Last trade
4 Nov 2026
Last filed
4 Nov 2026

Companies traded

Where they are an officer
NEOG NeogenOfficer · Diagnostics & Labs · last 4 Nov 20260 buys · 1 sell

Activity over time

Not enough dated trades to draw.

Every trade

TradedCompanyWhatAmount
4 Nov 2026filed 4 Nov 2026NEOG NeogenDiagnostics & LabsSEC FORM 4 Sold$115K9,051 at $12.67filing
3 Nov 2026filed 4 Nov 2026NEOG NeogenDiagnostics & LabsSEC FORM 4 Code M$192K16,207 at $11.82filing
3 Nov 2026filed 4 Nov 2026NEOG NeogenDiagnostics & LabsSEC FORM 4 Code F$85K7,156 at $11.82filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care1

Buys in green, sells in red, by the company’s sector.

Related people

Joe B. FreelsChief Commercial Officer · Chief Commercial Officer at Neogen, filing Form 4 there in the last year
Jeffrey D. CapelloDirector · Director at Neogen, filing Form 4 there in the last year
James C. BorelDirector · Director at Neogen, filing Form 4 there in the last year
Rafael A. RodriguezDirector · Director at Neogen, filing Form 4 there in the last year
Ronald D. GreenDirector · Director at Neogen, filing Form 4 there in the last year
Mikheal NassifCEO · Also traded NEOG in the last 90 days